Objectives: The impaired attenuation of pain by the application of a noxious conditioning stimulus at a segmentally distinct site, known as conditioned pain modulation (CPM), has been implicated in clinical pain states. Chronic lateral epicondylalgia (LE), which is characterized by lower pressure pain thresholds (PPTs) at sites remote to the affected elbow and spinal cord hyperexcitability, is a clinical pain state that might plausibly involve less efficacious CPM. This study aimed to determine whether LE exhibits a less efficacious CPM compared with that in pain-free controls.
L
ateral epicondylalgia (LE) is a painful and disabling musculoskeletal condition with significant individual and societal impact. [1] [2] [3] [4] Although unilateral LE is described clinically as a localized peripheral musculoskeletal condition, it exhibits characteristics of central sensitization. For example, there is evidence of lower pressure pain thresholds (PPTs) at remote sites, 3, 5 and spinal cord hyperexcitability (reduced nociceptive flexion reflex threshold) 6 when compared with controls who do not have pain.
One possible underlying mechanistic reason for widespread lower PPTs in conjunction with spinal cord hyperexcitability might be impaired endogenous pain inhibition. Conditioned Pain Modulation (CPM) is a laboratory-based measure of this endogenous inhibition system. It is the attenuation of pain at a body site by the application of a noxious conditioning stimulus at a segmentally distinct site. 7 A less efficacious CPM that reflects a poorer inherent pain suppression capacity 8 has been implicated in clinical pain states such as fibromyalgia, 9,10 knee osteoarthritis, 11 and whiplash, 12 but not in cases of persistent tendon pain. We hypothesized that there would be a less efficacious CPM in an upper-limb tendinopathy like LE.
The objective of this study was to evaluate CPM in LE patients compared with controls, and to better understand the relationship between CPM and clinical pain measures in individuals with LE.
MATERIALS AND METHODS

Participants
LE participants were included if they reported unilateral elbow pain for longer than 6 weeks 13 and presented with pain over the lateral humeral epicondyle, which was provoked by at least 2 of the following: gripping, resisted wrist or middle finger extension, or palpation 14 in conjunction with reduced pain-free grip (PFG) strength over their affected side. [14] [15] [16] Participants were recruited primarily through general advertisement in local community newspapers within the neighboring suburbs. A 2-stage screening process was used, which comprised a telephone interview followed by a clinical examination to determine eligibility for the study. LE participants were excluded if they had received an injection within the preceding 6 weeks, had concomitant neck and arm pain, or had evidence of other concomitant sources of lateral elbow pain including the following: exacerbation of elbow pain with movements or manual examination of the neck, pain localized over the radiohumeral joint, sensory disturbances in the affected hand and/or history of fractures within the preceding 10 years, elbow surgery, malignancy or inflammatory or arthritic disorder.
A control group was also recruited using a similar media campaign. Each control participant was matched to 1 LE participant based on sex and age (10 y epochs). Inclusion criteria were no history of neurological disorders or musculoskeletal pain in the last 12 months that required treatment. 17 Ethical approval was provided by the Institutional Medical Research Ethics Committee.
Experimental Test Stimulus (PPT)
PPT was used as the test stimulus because it has been widely used in characterizing LE as a reliable measure 18 of mechanical hyperalgesia. 19 PPT was determined with a handheld digital algometer (Somedic AB, Farsta, Sweden) mounted with a 1-cm 2 -diameter circular rubber probe. To assess PPT, the probe was held perpendicularly to the lateral epicondyle test site and the pressure increased at a constant rate of 40 kPa/s. Participants were positioned prone comfortably on a plinth with the algometer stop button held on by the nontested hand. The tested side of the arm was placed in approximately 90 degrees of elbow flexion. They were instructed to press the button when the first sensation of pain was experienced. PPT was defined as the pressure at which the participant perceived sensation that changed from pressure to the first sensation of pain.
Conditioning Stimulus (Painful Thermal Contact)
Contact heat was applied as the conditioning stimulus over the left calf for all participants using a Peltier elementbased thermode of 9.6 cm 2 (Thermotest system, Somedic AB, Farsta, Sweden). The temperature was adjusted through a step up/down by 0.51C method starting at 321C until the participant reported a pain visual analog scale (VAS) rating as 40 to 60 mm out of a possible 100 mm rating (100 representing worst pain imaginable).
Upon achieving the desired pain VAS rating, the conditioning heat stimulus remained in contact with the skin for the subsequent 4 minutes. The temperature of the conditioning heat stimulus used and pain VAS rating in sequential 2-minute epochs were recorded.
Clinical Measures of LE
LE was further characterized by way of PFG strength and the Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire. PFG is measured clinically in LE because gripping tasks are reported to reproduce the patient's lateral elbow pain. 20 In addition, PFG has been reported to correlate with pain and disability rated on the PRTEE score (r = À0.36). 21 PFG is the amount of force that the participant generates to the onset of pain, and when there is no pain this could be regarded as maximum grip strength. PFG is a highly reliable (Intra Class Coefficients > 0.97) and convenient clinical assessment tool that correlates more strongly with disability and perceived improvement than maximal grip strength in LE populations. 22, 23 PFG strength was measured using a digital grip dynamometer (MIE, Medical Research, Leeds, UK) with the patient in a supine position and with the tested elbow in relaxed extension and forearm pronated. 4, 24 The PRTEE questionnaire was used as a standardized quantitative assessment of pain and disability. It has been shown to have excellent test-retest reliability (r = 0.93) and good correlation with other functional scales, including the Disability of Arm and Shoulder (DASH) questionnaire (r = 0.87) in LE. 25 Questions are scored on an 11-point Likert scale, with the calculation of separate subscales for pain and function and a total score, ranging from 0 (no pain and no functional disability) to 100 (worst imaginable pain with a very significant functional disability). 25 
Sample Size Calculation
The estimated sample size per group was calculated on the basis of a previous study investigating CPM in another peripheral joint problem-namely, shoulder pain-which detected a mean difference of 37% (with an expected background SD of 40%) in CPM when compared with controls. 26 On the basis of a power of 0.8 at P = 0.05, it was calculated that 20 participants per group were required.
Procedure
During the familiarization and screening session, if participants were found to be eligible, they were given a description of the experimental procedure, and informed consent was gained. Demographic information (age, sex, height, and weight) was collected from all participants. In addition, LE participants reported their duration of symptoms (months) and completed the PRTEE questionnaire. Then the temperature of the conditioning heat stimulus, which elicited a pain VAS rating of between 40 and 60 mm, was determined for all participants. The determination of such conditioning stimuli intensity during the initial screening session was deemed necessary so as to familiarize the participants with the device and perceived sensation, to reduce the novelty of the experience during the actual experimental testing session, and most importantly to ensure that the participants were comfortable with the thermal form of pain without causing any undue stress or burn injury.
During the testing session (at least 48 h later), LE participants were asked to rate their worst level of pain over the past week using the pain VAS rating. Grip strength and PPT were measured by a single assessor (E.C.W.L). Participants were then allowed to rest for 20 minutes, so that they would be settled and prepared for the testing session. This was followed by the application of contact heat over the left calf. The temperature was ramped up to the predetermined temperature as per the initial familiarization session; it was moderately to highly reproducible (Intra Class Coefficients = 0.74). After 3 minutes of experiencing this heat stimulus and with the heat stimulus remaining in situ the participants were retested on grip strength (Fig. 1) . At the penultimate 2 minutes of conditioning stimulation, the pain VAS was evaluated with or without subsequent adjustment (through a step up/down by 0.51C method) of the temperature, depending on whether the pain VAS rating was maintained between 40 and 60 mm. This was monitored to ensure that the conditioning heat stimulus remained at a moderately noxious level before the reassessment of PPT over the lateral epicondyles (Fig. 1). triplicate PPT measurements were then averaged. As per recommendations, 27 data were represented as the mean (SD) for both groups before and during the heat stimulus, as well as the change between before and during expressed as a percentage of the PPT measured before the application of the conditioning heat stimulus (CPM).
Descriptive statistics were calculated for age (years), sex, body mass index (kg/m 2 ), PFG/maximum strength, and PPT for control and LE groups. In addition, descriptive statistics were calculated for worst pain VAS rating over the past week, duration of symptomatic elbow (in months), and PRTEE scores (including pain and disability subscale scores) in participants with unilateral LE. The control and LE groups were compared with respect to age, body mass index, PFG/maximum strength, and PPT using the independent-samples t test and with respect to sex using the w 2 test. As per a previous study, 6 we assigned the dominant side of the control group against the affected side of LE participants, as LE is more likely to occur over the dominant side. 28, 29 A 2-way analysis of variance was conducted for CPM with factors of side (LE affected/control dominant, LE unaffected/control nondominant) and group (LE, control). Significant effects were followed up with post hoc pairwise comparisons and Bonferroni corrections for multiple comparisons. Standardized mean differences for pairwise comparisons were also calculated as an indicator of effect size. Effect sizes were interpreted as trivial (0 to 0.2), small (0.2 to 0.6), moderate (0.6 to 1.2), and large (> 1.2). 30 Pearson correlation coefficients were calculated to assess the relationship between the CPM score and clinical pain measures of LE-that is, worst pain rating over the previous week-and PRTEE pain subscale score. The indicative size of the correlation coefficients was interpreted as trivial (0 to 0.1), small (0.1 to 0.3), moderate (0.3 to 0.5), large (0.5 to 0.7), very large (0.7 to 0.9), and nearly perfect (0.9 to 1.0). 30 All statistical analyses were carried out using IBM SPSS Statistics for Windows, Version 22.0, SPSS Inc., Chicago, IL 60606. For all analyses significance was set at P < 0.05. (Fig. 3) . There was no change in PFG on the affected side in LE [mean difference (confidence interval, CI), 2.5 (À4.92 to 9.92); mean PFG preheat (SD) = 91.25 (52.23) N, mean PFG during heat (SD) = 93.75 (53.49) N]. The temperature of the conditioning heat stimulus used and the pain VAS rated during the testing session were not different between groups or sides ( Table 2) .
RESULTS
Twenty
The 2-way analysis of variance for CPM, which was based on changes in PPT, showed a significant main effect for group (F (1,40) = 13.458, P = 0.001), but not side (F (1,40) = 1.758, P = 0.192) or side-by-group interaction (F (1, 40) = 0.004, P = 0.951). The mean difference in CPM between groups (95% CI) was 24.5% (11.0 to 38.0, P = 0.001, standardized mean differences = 1.13) ( Table 3) .
Within the LE group, there was a small to moderate correlation between CPM and the PRTEE pain subscale score (r = À 0.452, P = 0.045), but not worst pain rating over the past week (r = À 0.359, P = 0.12).
DISCUSSION
We measured the effect of a painful thermal conditioning stimulus applied over the calf on PPT at the lateral epicondyle in patients with LE and found minimal impact on the PPT recorded before applying the conditioning stimulus (ie, change in PPT from preheat pain conditioning stimulus ranging from À17.18 to À2.18 kPa). This was different from the range of 65.92 to 99.11 kPa change observed in the pain-free control group and suggests that individuals with LE, on average, do not exhibit CPM.
Our finding of less efficacious CPM among patients with LE concurs with studies investigating other musculoskeletal pain disorders, such as shoulder pain, 26 whiplash, 12 fibromyalgia, 31 hip osteoarthritis, 32 and knee osteoarthritis. 33 The determination of a less efficacious CPM is in part dependent upon the efficacy of the observed condition pain modulation in the comparator group. The control participants in our study displayed a significant 24.2% to 24.8% greater change (in CPM) than participants with LE. In a study of CPM in patients with shoulder pain (by Valencia et al, 26 Table 2 therein), control participants displayed 37.0% greater change (in CPM) compared with participants with shoulder pain (see Table 2 therein). In another study by Ng et al, 12 it is estimated that the control participants exhibited only 5.1% greater difference (in CPM) than participants with whiplash-associated disorder.
It is important to note that there was a plethora of different test and conditioning stimuli used to investigate CPM across the literature. For example, we used pressure pain threshold as the test stimulus as opposed to heat pain threshold, 12, 31 and pain ratings in response to a predetermined suprathreshold pain stimuli. 26 Likewise, we used a conditioning heat stimulus as opposed to a conditioning cold pressor stimulus, 12, 26, 31 or pressure cuff stimulus. 32, 33 These differences in testing parameters could have accounted for the different CPM magnitudes reported from different studies. Conversely, Lewis et al 34 reported that the type of test stimulus or conditioning stimulus does not appear to influence the CPM effect significantly. Nevertheless, it would appear that the phenomenon of endogenous analgesia in pain-free individuals is quite robust, regardless of conditioning stimulus. Chronic LE exhibits heightened spinal cord excitability, 6 which plausibly may be a function of a less efficacious endogenous pain inhibition (as found in this study), an ongoing nociceptive afferent input, or a combination of both. It is plausible that repeated loading of the extensor carpi radialis brevis tendon occurring with typical activities (ie, repetitive manual tasks) in those with LE might contribute to ongoing nociceptive afferent input and increase the excitability of spinal cord neurons. Somewhat indirect evidence for this possibility might be inferred from previous work that showed removing the source of ongoing nociceptive input during hip joint replacement surgery restores the efficacy of condition pain modulation. 32 However, LE may well represent the full spectrum of varying pain sensitization states (peripheral and/or central sensitization) or no pain sensitization at all. 35 More importantly, peripheral sensitization is not a prerequisite for the presence of central sensitization, and vice versa. 35 The other biologically plausible reasons include, but are not limited to, changes in neurotransmitter release/receptor availability, 36 altered spinal level inhibitory interneuron function, 37 and activation of latent spinal level connections. 38 Further studies are required to better understand the relationship between heightened spinal cord excitability and less efficacious CPM in chronic pain. It is interesting to note that the conditioning thermal pain stimulus did not change PFG in the LE group [mean PFG preheat (SD) = 91.25 (52.23) N, mean PFG during heat (SD) = 93.75 (53.49) N]. Although PFG is sensitive in detecting LE, it does not elicit pain in the unaffected elbow (of patients with unilateral LE or in healthy controls) where it is essentially a maximum grip strength test. That it is not a pain threshold or tolerance test makes it inappropriate as an experimental test stimulus in a CPM study. PFG is a mechanical pain provocation test, whereby much lower grip force elicits pain, presumably through direct tension and stress of the connective tissues at the elbow tendons of the wrist extensor muscles. Notwithstanding that it is not a candidate as an experimental test stimulus in assessing CPM, it is interesting to note that like PPT it did not change with the painful thermal conditioning stimulus. Both PFG and PPT have been shown to improve with some treatments (eg, manual therapy 4, 39 ) . It is tempting to speculate that treatments that reduce deficits in PPT and PFG in LE might be doing so through stimulating an endogenous inhibitory mechanism, as suggested previously. 16, [40] [41] [42] More recently, joint mobilization has been demonstrated to enhance endogenous descending inhibitory pain mechanism in painful knee osteoarthritis. 43 Our data suggest that CPM is a measure of specific pain experience in LE. We found that higher CPM was associated with lower pain severity as measured by the PRTEE pain subscale, but not with overall pain severity rated on a VAS. The latter concurs with another study that reported a lack of correlation between CPM and numerical rating scale of temporomandibular disorder pain. 44 This is plausibly because a condition-specific pain measure, such as the PRTEE pain subscale, relates more specifically to the pain experience during selected functional activities or tasks typically reported by LE participants, whereas a pain VAS rating does not have such context. Although the correlation coefficient for pain severity was not significant or as large as that for PRTEE, we cannot discount that with a larger sample size it might have been statistically significant. Further work might evaluate whether a measure of CPM has any clinical utility (eg, prognosis). There are some aspects of this study that require attention when drawing inferences from its findings. First, it is important to consider that we did not blind the assessor to participant status (LE or control), but the assessor and participant were blind to the PPT preheat data while measuring PPT during the application of heat stimulus. In addition, the participants were also blind to the temperature of the heat used during the application of the noxious conditioning heat stimulus. Second, it is noteworthy that the large SD (Table 3 , Fig. 3 ) around the group mean data and the point estimates of effect suggest that a deficit in endogenous pain inhibition might not be present in every LE patient. One of the reasons for this might well be that we only applied the conditioning stimulus to one limb but LE was present in some on the ipsilateral side to the conditioning stimulus and in others on the contralateral side. Third, there was no significant difference in PPT between the LE unaffected side and the control nondominant side, which suggests that our current cohort comprised LE participants who did not have widespread sensory hypersensitivity. Last, as the study was cross-sectional in nature and involved a patient group that did not have lower pressure pain threshold at remote sites to the affected elbow, it is not possible to make any conclusions regarding causality between impaired CPM and widespread hyperalgesia in LE reported in other studies. 7 Despite these limitations, the current study represents a novel contribution to the literature by exploring CPM in a chronic tendinopathic musculoskeletal pain model.
CONCLUSIONS
The present investigation showed that a remotely applied painful heat stimulus produced an increase in pressure pain threshold at the lateral elbow in pain-free participants, which was not present in participants who had LE. This seems to indicate that there is less efficacious endogenous modulation of mechanical pain in those with persistent lateral elbow tendinopathy. 
